Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:Q16763 UBE2S

Class:IdReferenceGeneProduct:66751
_chainChangeLogchain:1-222 added on Sat February 7 2015
_displayNameUniProt:Q16763 UBE2S
_timestamp2025-02-21 19:14:06
chainchain:1-222
checksum2842DC3DCD2AFCB5
commentFUNCTION Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins (PubMed:19820702, PubMed:19822757, PubMed:22496338, PubMed:27259151). Catalyzes 'Lys-11'-linked polyubiquitination. Acts as an essential factor of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis (PubMed:19820702, PubMed:19822757, PubMed:27259151, PubMed:27910872). Acts by specifically elongating 'Lys-11'-linked polyubiquitin chains initiated by the E2 enzyme UBE2C/UBCH10 on APC/C substrates, enhancing the degradation of APC/C substrates by the proteasome and promoting mitotic exit (PubMed:19820702, PubMed:19822757, PubMed:27259151). Also acts by elongating ubiquitin chains initiated by the E2 enzyme UBE2D1/UBCH5 in vitro; it is however unclear whether UBE2D1/UBCH5 acts as an E2 enzyme for the APC/C in vivo. Also involved in ubiquitination and subsequent degradation of VHL, resulting in an accumulation of HIF1A (PubMed:16819549). In vitro able to promote polyubiquitination using all 7 ubiquitin Lys residues, except 'Lys-48'-linked polyubiquitination (PubMed:20061386, PubMed:20622874).CATALYTIC ACTIVITY S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.PATHWAY Protein modification; protein ubiquitination.SUBUNIT Component of the APC/C complex, composed of at least 14 distinct subunits that assemble into a complex of at least 19 chains with a combined molecular mass of around 1.2 MDa. Within this complex, directly interacts with ANAPC2 and ANAPC4 (PubMed:27259151). Interacts with CDC20, FZR1/CDH1 and VHL (PubMed:16819549, PubMed:19822757).INTERACTION Autoubiquitinated by the APC/C complex during G1, leading to its degradation by the proteasome.SIMILARITY Belongs to the ubiquitin-conjugating enzyme family.
descriptionrecommendedName: Ubiquitin-conjugating enzyme E2 S ecNumber evidence="5 6 7 12"2.3.2.23 alternativeName: E2 ubiquitin-conjugating enzyme S alternativeName: E2-EPF alternativeName: Ubiquitin carrier protein S alternativeName: Ubiquitin-conjugating enzyme E2-24 kDa alternativeName: Ubiquitin-conjugating enzyme E2-EPF5 alternativeName: Ubiquitin-protein ligase S
geneNameUBE2S
E2EPF
OK/SW-cl.73
identifierQ16763
isSequenceChangedFALSE
keyword3D-structure
Acetylation
ATP-binding
Cell cycle
Cell division
Nucleotide-binding
Phosphoprotein
Proteomics identification
Reference proteome
Transferase
Ubl conjugation
Ubl conjugation pathway
modified[InstanceEdit:9836292] Weiser, Joel, 2023-05-25
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9917590] Weiser, Joel, 2024-08-09
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
[InstanceEdit:9939033] Weiser, Joel, 2025-02-21
nameUBE2S
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:9005045] ENSEMBL:ENSG00000108106 UBE2S [Homo sapiens]
secondaryIdentifierUBE2S_HUMAN
Q9BTC1
sequenceLength222
species[Species:48887] Homo sapiens
(referenceEntity)[EntityWithAccessionedSequence:947622] UBE2S [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:8852051] UBE2S [nucleoplasm] [Homo sapiens]
[EntityWithAccessionedSequence:8864164] Ub-C95-UBE2S [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:8864181] Ub-C95-UBE2S [nucleoplasm] [Homo sapiens]
(referenceSequence)[ModifiedResidue:8864173] S-(glycyl)-L-cysteine (Cys-Gly) at 95
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:Q16763 UBE2S (66751)